Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

460.79
BATS BZX Real-Time Price
As of 11:11am ET
 +8.37 / +1.85%
Today’s Change
269.50
Today|||52-Week Range
495.50
+12.32%
Year-to-Date

Today’s Trading

Previous close452.42
Today’s open454.75
Day’s range450.02 - 459.89
Volume238,410
Average volume (3 months)817,969
Market cap$46.4B
Dividend yield--
Data as of 10:58am ET, 04/21/2015

Growth & Valuation

Earnings growth (last year)-19.42%
Earnings growth (this year)+5.12%
Earnings growth (next 5 years)+26.00%
Revenue growth (last year)+33.96%
P/E ratio149.5
Price/Sales14.64
Price/Book18.23

Competitors

 Today’s
change
Today’s
% change
ALNYAlnylam Pharmaceutic...+4.34+3.66%
QQuintiles Transnatio...+0.01+0.02%
ISISIsis Pharmaceuticals...+0.90+1.38%
ICLRICON PLC+0.09+0.13%
Data as of 11:13am ET, 04/21/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)$2.71
Annual revenue (last year)$2.8B
Annual profit (last year)$348.1M
Net profit margin12.34%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Leonard S. Schleifer
Chief Financial Officer
Robert E. Landry
Corporate headquarters
Tarrytown, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers